Department of Cardiovascular Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.
School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Front Immunol. 2024 Jun 11;15:1395596. doi: 10.3389/fimmu.2024.1395596. eCollection 2024.
Vascular calcification (VC) is considered a common pathological process in various vascular diseases. Accumulating studies have confirmed that VC is involved in the inflammatory response in heart disease, and SPP1+ macrophages play an important role in this process. In VC, studies have focused on the physiological and pathological functions of macrophages, such as pro-inflammatory or anti-inflammatory cytokines and pro-fibrotic vesicles. Additionally, macrophages and activated lymphocytes highly express SPP1 in atherosclerotic plaques, which promote the formation of fatty streaks and plaque development, and SPP1 is also involved in the calcification process of atherosclerotic plaques that results in heart failure, but the crosstalk between SPP1-mediated immune cells and VC has not been adequately addressed. In this review, we summarize the regulatory effect of SPP1 on VC in T cells, macrophages, and dendritic cells in different organs' VC, which could be a potential therapeutic target for VC.
血管钙化(VC)被认为是各种血管疾病中的一种常见病理过程。越来越多的研究证实,VC 参与了心脏病中的炎症反应,而 SPP1+巨噬细胞在这个过程中起着重要作用。在 VC 中,研究集中在巨噬细胞的生理和病理功能上,例如促炎或抗炎细胞因子和促纤维化小泡。此外,巨噬细胞和活化的淋巴细胞在动脉粥样硬化斑块中高度表达 SPP1,这促进了脂肪条纹的形成和斑块的发展,SPP1 也参与了导致心力衰竭的动脉粥样硬化斑块的钙化过程,但 SPP1 介导的免疫细胞与 VC 之间的串扰尚未得到充分解决。在这篇综述中,我们总结了 SPP1 在不同器官 VC 中的 T 细胞、巨噬细胞和树突状细胞中对 VC 的调节作用,这可能是 VC 的一个潜在治疗靶点。
Vascular. 2022-10
Biochem Biophys Res Commun. 2012-7-17
Kidney Blood Press Res. 2025
Inflammation. 2025-5-8
Front Cardiovasc Med. 2025-2-18
J Neuroinflammation. 2025-2-22
Circulation. 2024-1-16
Atherosclerosis. 2024-1
J Clin Invest. 2023-12-1
Alzheimers Dement. 2024-1